Search Results - "AURIVILLIUS, Magnus" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD

Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD

by Rabe, Klaus F, Martinez, Fernando J, Ferguson, Gary T, Wang, Chen, Singh, Dave, Wedzicha, Jadwiga A, Trivedi, Roopa, St. Rose, Earl, Ballal, Shaila, McLaren, Julie, Darken, Patrick, Aurivillius, Magnus, Reisner, Colin, Dorinsky, Paul
Published in The New England journal of medicine (02.07.2020)

Get full text

Journal Article

Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2 -agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial

Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2 -agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial

by Bleecker, Eugene R, Prof, FitzGerald, J Mark, Prof, Chanez, Pascal, Prof, Papi, Alberto, Prof, Weinstein, Steven F, Prof, Barker, Peter, PhD, Sproule, Stephanie, MMath, Gilmartin, Geoffrey, MD, Aurivillius, Magnus, MD, Werkström, Viktoria, MD, Goldman, Mitchell, MD
Published in The Lancet (British edition) (29.10.2016)

Get full text

Journal Article

Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

by FitzGerald, J Mark, Dr, Bleecker, Eugene R, Prof, Nair, Parameswaran, Prof, Korn, Stephanie, MD, Ohta, Ken, MD, Lommatzsch, Marek, Prof, Ferguson, Gary T, MD, Busse, William W, Prof, Barker, Peter, PhD, Sproule, Stephanie, MMath, Gilmartin, Geoffrey, MD, Werkström, Viktoria, MD, Aurivillius, Magnus, MD, Goldman, Mitchell, MD
Published in The Lancet (British edition) (29.10.2016)

Get full text

Journal Article

Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study

Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study

by Martinez, Fernando J, Rabe, Klaus F, Ferguson, Gary T, Wedzicha, Jadwiga A, Singh, Dave, Wang, Chen, Rossman, Kimberly, St Rose, Earl, Trivedi, Roopa, Ballal, Shaila, Darken, Patrick, Aurivillius, Magnus, Reisner, Colin, Dorinsky, Paul
Published in American journal of respiratory and critical care medicine (01.03.2021)

Get full text

Journal Article

Effect of inhaled budesonide/formoterol fumarate dihydrate delivered via two different devices on lung function in patients with COPD and low peak inspiratory flow

Effect of inhaled budesonide/formoterol fumarate dihydrate delivered via two different devices on lung function in patients with COPD and low peak inspiratory flow

by Huber, Bärbel, Keller, Claus, Jenkins, Martin, Raza, Abid, Aurivillius, Magnus
Published in Therapeutic advances in respiratory disease (01.07.2022)

Get full text

Journal Article

Relationship between risk, cumulative burden of exacerbations and mortality in patients with COPD: modelling analysis using data from the ETHOS study

Relationship between risk, cumulative burden of exacerbations and mortality in patients with COPD: modelling analysis using data from the ETHOS study

by Rhodes, Kirsty, Jenkins, Martin, de Nigris, Enrico, Aurivillius, Magnus, Ouwens, Mario
Published in BMC medical research methodology (25.05.2022)

Get full text

Journal Article

A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease

A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease

by Usmani, Omar, Roche, Nicolas, Wahab, Ezanul, Israel, Samuel, Jenkins, Martin, Trivedi, Roopa, Dorinsky, Paul, Aurivillius, Magnus
Published in Respiratory research (07.10.2021)

Get full text

Journal Article

Efficacy and safety of benralizumab in Japanese patients with severe, uncontrolled eosinophilic asthma

Efficacy and safety of benralizumab in Japanese patients with severe, uncontrolled eosinophilic asthma

by Ohta, Ken, Adachi, Mitsuru, Tohda, Yuji, Kamei, Tadashi, Kato, Motokazu, Mark Fitzgerald, J., Takanuma, Masayuki, Kakuno, Tadahiro, Imai, Nobuyuki, Wu, Yanping, Aurivillius, Magnus, Goldman, Mitchell
Published in Allergology international (01.04.2018)

Get full text

Journal Article

Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler versus dual therapies in patients with COPD: a sub-study of the ETHOS trial

Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler versus dual therapies in patients with COPD: a sub-study of the ETHOS trial

by Rabe, Klaus F., Martinez, Fernando J., Singh, Dave, Trivedi, Roopa, Jenkins, Martin, Darken, Patrick, Aurivillius, Magnus, Dorinsky, Paul
Published in Therapeutic advances in respiratory disease (2021)

Get full text

Journal Article

Functional respiratory imaging assessment of budesonide/glycopyrrolate/formoterol fumarate and glycopyrrolate/formoterol fumarate metered dose inhalers in patients with COPD: the value of inhaled corticosteroids

Functional respiratory imaging assessment of budesonide/glycopyrrolate/formoterol fumarate and glycopyrrolate/formoterol fumarate metered dose inhalers in patients with COPD: the value of inhaled corticosteroids

by van den Berge, Maarten, De Backer, Jan, Van Holsbeke, Cedric, De Backer, Wilfried, Trivedi, Roopa, Jenkins, Martin, Dorinsky, Paul, Aurivillius, Magnus
Published in Respiratory research (01.07.2021)

Get full text

Journal Article

Efficacy and safety of benralizumab in Japanese patients with severe, uncontrolled eosinophilic asthma

Efficacy and safety of benralizumab in Japanese patients with severe, uncontrolled eosinophilic asthma

by Ken Ohtaa, Mitsuru Adachib, Yuji Tohdac, Tadashi Kameid, Motokazu Katoe, J. Mark Fitzgeraldf, Masayuki Takanumag, Tadahiro Kakunog, Nobuyuki Imaig, Yanping Wuh, Magnus Aurivilliusi, Mitchell Goldmanh
Published in Allergology International (01.04.2018)

Get full text

Journal Article

Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β 2 -agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial

Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β 2 -agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial

by Bleecker, Eugene R, FitzGerald, J Mark, Chanez, Pascal, Papi, Alberto, Weinstein, Steven F, Barker, Peter, Sproule, Stephanie, Gilmartin, Geoffrey, Aurivillius, Magnus, Werkström, Viktoria, Goldman, Mitchell
Published in The Lancet (British edition) (29.10.2016)

Get full text

Journal Article

Benralizumab, an anti-interleukin-5 receptor [alpha] monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

Benralizumab, an anti-interleukin-5 receptor [alpha] monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

by FitzGerald, J Mark, Bleecker, Eugene R, Nair, Parameswaran, Korn, Stephanie, Ohta, Ken, Lommatzsch, Marek, Ferguson, Gary T, Busse, William W, Barker, Peter, Sproule, Stephanie, Gilmartin, Geoffrey, Werkström, Viktoria, Aurivillius, Magnus, Goldman, Mitchell
Published in The Lancet (British edition) (29.10.2016)

Get full text

Journal Article

Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial

Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial

by Ferguson, Gary T, Rabe, Klaus F, Martinez, Fernando J, Fabbri, Leonardo M, Wang, Chen, Ichinose, Masakazu, Bourne, Eric, Ballal, Shaila, Darken, Patrick, DeAngelis, Kiernan, Aurivillius, Magnus, Dorinsky, Paul, Reisner, Colin
Published in The lancet respiratory medicine (01.10.2018)

Get more information

Journal Article

Immunoglobulin heavy G2 chain (IGHG2) gene restriction in the development of severe respiratory syncytial virus infection

Immunoglobulin heavy G2 chain (IGHG2) gene restriction in the development of severe respiratory syncytial virus infection

by Aurivillius, Magnus, Øymar, Knut, Oxelius, Vivi-Anne
Published in Acta Paediatrica (01.04.2005)

Get full text

Journal Article

Pulmonary deposition of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler formulated using co-suspension delivery technology in healthy male subjects

Pulmonary deposition of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler formulated using co-suspension delivery technology in healthy male subjects

by Israel, Samuel, Kumar, Ashish, DeAngelis, Kiernan, Aurivillius, Magnus, Dorinsky, Paul, Roche, Nicolas, Usmani, Omar S.
Published in European journal of pharmaceutical sciences (01.10.2020)

Get full text

Journal Article

Relative bioavailability of budesonide/glycopyrrolate/formoterol fumarate triple therapy delivered using next generation propellants with low global warming potential

Relative bioavailability of budesonide/glycopyrrolate/formoterol fumarate triple therapy delivered using next generation propellants with low global warming potential

by Aurivillius, Magnus, Bednarczyk, Artur, Kokot, Marek, Madriaga, Jonathan, Mei, Jie, Collison, Kathryn, Surujbally, Raulin, Archbell, James, Joshi, Vidya, Gillen, Michael
Published in Pulmonary pharmacology & therapeutics (01.12.2023)

Get full text

Journal Article

A SCINTIGRAPHY STUDY OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE IN PATIENTS WITH COPD

A SCINTIGRAPHY STUDY OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE IN PATIENTS WITH COPD

by Usmani, Omar, Roche, Nicolas, Abd Wahab, Ezanul, Israel, Samuel, Jenkins, Martin, Trivedi, Roopa, Dorinsky, Paul, Aurivillius, Magnus
Published in Chest (01.10.2020)

Get full text

Journal Article

Single-Use Autoinjector Functionality and Reliability for At-Home Benralizumab Administration: GRECO Trial Results

Single-Use Autoinjector Functionality and Reliability for At-Home Benralizumab Administration: GRECO Trial Results

by Barker, Peter, Ferguson, Gary T., Cole, Jeremy, Aurivillius, Magnus, Roussel, Paul, Martin, Ubaldo
Published in Journal of allergy and clinical immunology (01.02.2019)

Get full text

Journal Article

BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE METERED DOSE INHALER, FORMULATED USING CO-SUSPENSION DELIVERY TECHNOLOGY, IMPROVES LUNG FUNCTION AND EXACERBATION OUTCOMES IN PATIENTS WITH COPD WITHOUT A RECENT HISTORY OF EXACERBATIONS: SUBGROUP ANALYSIS OF KRONOS STUDY

BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE METERED DOSE INHALER, FORMULATED USING CO-SUSPENSION DELIVERY TECHNOLOGY, IMPROVES LUNG FUNCTION AND EXACERBATION OUTCOMES IN PATIENTS WITH COPD WITHOUT A RECENT HISTORY OF EXACERBATIONS: SUBGROUP ANALYSIS OF KRONOS STUDY

by Martinez, Fernando, Ferguson, Gary, Bourne, Eric, Ballal, Shaila, Darken, Patrick, DeAngelis, Kiernan, Aurivillius, Magnus, Dorinsky, Paul, Reisner, Colin
Published in Chest (01.10.2019)

Get full text

Journal Article